Euclises is Drug Discovery in United States that focus on novel pain business. Founded in 2011. They cover business area such as developer, novel pain and cancer medication, use, a portfolio, cancer treatment, its proprietary Euclicoxib platform, physician, advanced new molecule, combination, both immune checkpoint, EGFR inhibitor.
2011
( 13 years old in 2024 )
Novel Pain
-
BioGenerator Accelerator Labs
4340 Duncan Avenue, Suite 240
Saint Louis, MO 63110
United States
Private
developernovel pain and cancer medicationusea portfoliocancer treatmentits proprietary Euclicoxib platformphysicianadvanced new moleculecombinationboth immune checkpointEGFR inhibitor
* We use standard office opening hours in near Euclises's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Euclises is Drug Discovery business from United States that founded in 2011 (13 years old in 2024), Euclises business is focusing on Novel Pain.
Euclises headquarter office and corporate office address is located in BioGenerator Accelerator Labs 4340 Duncan Avenue, Suite 240 Saint Louis, MO 63110 United States.
Euclises was founded in United States.
In 2024, Euclises is currently focus on novel pain sector.
Above is snippet of Google Trends for "novel pain" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Euclises, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
